Correction to: Scientific Reports https://doi.org/10.1038/s41598-017-15492-5, published online 10 November 2017
This Article contains errors.
As a result of errors during figure assembly Fig 6B Radotinib/c-kit image is a duplication of Fig 6A Radotinib/Apaf-1 image, and Fig S2B Radotinib PARP image is a duplication of Fig S3 HEL 92.1.7 PARP image.
The corrected Figure 6 and Figure S2B are shown below as Figure 1 and Figure 2.
Corrected version of Figure 6.
Corrected version of Figure S2.
Additionally, original images of the membranes showing Radotinib/Apaf-1, Radotinib/c-kit, and Radotinib/PARP results are shown below as Figure 3, 4, and 5, respectively.
Original image of the membranes showing Radotinib/Apaf-1, corresponding to Fig 6A.
Original image of the membranes showing Radotinib/c-kit, corresponding to Fig 6B.
Original image of the membranes showing Radotinib/PARP, corresponding to Fig S2B.
The conclusions of the Article are not affected by these changes.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Heo, SK., Noh, EK., Kim, J.Y. et al. Author Correction: Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death. Sci Rep 11, 23281 (2021). https://doi.org/10.1038/s41598-021-02577-5
Published:
DOI: https://doi.org/10.1038/s41598-021-02577-5
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
